Article
BRDKRM: An Explainable Framework for Disease Modifying Drug Identification
2024-09-26
Abstract excerpt
Drug classification into disease-modifying (DM) and symptomatic (SYM) categories is crucial for clinical decision-making and therapeutic strategy development. To address the limitations of current methods, which often lack transparency and interpretability, we propose the Boundary Restricted Dynamic Key Route Mapping (BRDKRM) framework. This novel approach leverages the contextual overlap between disease and drug...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 53c10f97-ea9a-5c9f-9b30-19a4a6d02540
- DOI
- 10.1101/2024.09.24.614653
